Mercer Global Advisors
WVE icon

Mercer Global Advisors’s Wave Life Sciences WVE Stock Holding History

Mercer Global Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
49,531
+36,905
+292% +$245K ﹤0.01% 2855
2026
Q1 		$91.5K Buy
+12,626
New +$164K ﹤0.01% 3037

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Mercer Global Advisors's WVE Position: Q2 2026 in Review

Mercer Global Advisors increased its Wave Life Sciences (WVE) stake by 292% in Q2 2026, buying an estimated $245K and bringing the position to 49,531 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Mercer Global Advisors first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Mercer Global Advisors held 49,531 shares of Wave Life Sciences worth $288K as of Q2 2026.
  • Mercer Global Advisors bought 36,905 Wave Life Sciences shares in Q2 2026, an estimated $245K.
  • Wave Life Sciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2855 holding.
  • Mercer Global Advisors first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.